{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:46:32Z","timestamp":1794473192940,"version":"4.9.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,20]]},"DOI":"10.7759\/cureus.29357","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T12:55:30Z","timestamp":1663678530000},"source":"Crossref","is-referenced-by-count":1,"title":["A Peculiar Case of Recurrent Coronary Artery Thrombosis"],"prefix":"10.7759","author":[{"given":"Samuel","family":"Nwaobi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aarushi","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199812033392303","article-title":"A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting","volume":"339","author":"Leon MB","year":"1998","unstructured":"Leon MB, Baim DS, Popma JJ, et al.. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting. N Engl J Med. 1998, 339:1665-1671. 10.1056\/NEJM199812033392303","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199604253341702","article-title":"A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents","volume":"334","author":"Sch\u00f6mig A","year":"1996","unstructured":"Sch\u00f6mig A, Neumann FJ, Kastrati A, et al.. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med. 1996, 334:1084-1089. 10.1056\/NEJM199604253341702","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study","volume":"125","author":"R\u00e4ber L","year":"2012","unstructured":"R\u00e4ber L, Magro M, Stefanini GG, et al.. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study. Circulation. 2012, 125:1110-1121. 10.1161\/CIRCULATIONAHA.111.058560","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.99.1.44","article-title":"Pathology of acute and chronic coronary stenting in humans","volume":"99","author":"Farb A","year":"1999","unstructured":"Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, Schwartz RS, Virmani R. Pathology of acute and chronic coronary stenting in humans. Circulation. 1999, 99:44-52. 10.1161\/01.cir.99.1.44","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery","volume":"134","author":"Levine GN","year":"2016","unstructured":"Levine GN, Bates ER, Bittl JA, et al.. 2016 ACC\/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention, 2011 ACCF\/AHA guideline for coronary artery bypass graft surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease, 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction, 2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes, and 2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery. Circulation. 2016, 134:e123-e155. 10.1161\/CIR.0000000000000404","journal-title":"Circulation"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli M","year":"2018","unstructured":"Valgimigli M, Bueno H, Byrne RA, et al.. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018, 39:213-260. 10.1093\/eurheartj\/ehx419","journal-title":"Eur Heart J"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1655986","article-title":"Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on thrombophilia (EMET-Study)","volume":"77","author":"Mateo J","year":"1997","unstructured":"Mateo J, Oliver A, Borrell M, et al.. Laboratory evaluation and clinical characteristics of 2,132 consecutive unselected patients with venous thromboembolism - results of the Spanish Multicentric Study on thrombophilia (EMET-Study). Thromb Haemost. 1997, 77:444-451. 10.1055\/s-0038-1655986","journal-title":"Thromb Haemost"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.118.5.1405","article-title":"Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism","volume":"118","author":"Margaglione M","year":"2000","unstructured":"Margaglione M, Brancaccio V, De Lucia D, Martinelli I, Ciampa A, Grandone E, Di Minno G. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism. Chest. 2000, 118:1405-1411. 10.1378\/chest.118.5.1405","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0167-5273(02)00186-9","article-title":"Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death","volume":"85","author":"Soeki T","year":"2002","unstructured":"Soeki T, Tamura Y, Shinohara H, et al.. Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death. Int J Cardiol. 2002, 85:277-283. 10.1016\/s0167-5273(02)00186-9","journal-title":"Int J Cardiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2817","article-title":"Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women","volume":"89","author":"Rosendaal FR","year":"1997","unstructured":"Rosendaal FR, Siscovick DS, Schwartz SM, et al.. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood. 1997, 89:2817-2821. 10.1182\/blood.V89.8.2817","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1253\/circj.cj-09-0982","article-title":"Basic principles of platelet biology and clinical implications","volume":"74","author":"Angiolillo DJ","year":"2010","unstructured":"Angiolillo DJ, Ueno M, Goto S. Basic principles of platelet biology and clinical implications. Circ J. 2010, 74:597-607. 10.1253\/circj.cj-09-0982","journal-title":"Circ J"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.04.047","article-title":"Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate","volume":"56","author":"Bonello L","year":"2010","unstructured":"Bonello L, Tantry US, Marcucci R, et al.. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010, 56:919-933. 10.1016\/j.jacc.2010.04.047","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8703627","article-title":"The role of clopidogrel in 2020: a reappraisal","volume":"2020","author":"Patti G","year":"2020","unstructured":"Patti G, Micieli G, Cimminiello C, Bolognese L. The role of clopidogrel in 2020: a reappraisal. Cardiovasc Ther. 2020, 2020:8703627. 10.1155\/2020\/8703627","journal-title":"Cardiovasc Ther"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0716","article-title":"Oral antiplatelet therapy after acute coronary syndrome: a review","volume":"325","author":"Kamran H","year":"2021","unstructured":"Kamran H, Jneid H, Kayani WT, Virani SS, Levine GN, Nambi V, Khalid U. Oral antiplatelet therapy after acute coronary syndrome: a review. JAMA. 2021, 325:1545-1555. 10.1001\/jama.2021.0716","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0706482","article-title":"Prasugrel versus clopidogrel in patients with acute coronary syndromes","volume":"357","author":"Wiviott SD","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, et al.. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007, 357:2001-2015. 10.1056\/NEJMoa0706482","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.799403","article-title":"Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases","volume":"119","author":"van Werkum JW","year":"2009","unstructured":"van Werkum JW, Heestermans AA, de Korte FI, et al.. Long-term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation. 2009, 119:828-834. 10.1161\/CIRCULATIONAHA.108.799403","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(08)61845-0","article-title":"Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study","volume":"373","author":"Collet JP","year":"2009","unstructured":"Collet JP, Hulot JS, Pena A, et al.. Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet. 2009, 373:309-317. 10.1016\/s0140-6736(08)61845-0","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.12.071","article-title":"Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis","volume":"56","author":"Hulot JS","year":"2010","unstructured":"Hulot JS, Collet JP, Silvain J, et al.. Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis. J Am Coll Cardiol. 2010, 56:134-143. 10.1016\/j.jacc.2009.12.071","journal-title":"J Am Coll Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.1543","article-title":"Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis","volume":"304","author":"Mega JL","year":"2010","unstructured":"Mega JL, Simon T, Collet JP, et al.. Reduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysis. JAMA. 2010, 304:1821-1830. 10.1001\/jama.2010.1543","journal-title":"JAMA"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808227","article-title":"Genetic determinants of response to clopidogrel and cardiovascular events","volume":"360","author":"Simon T","year":"2009","unstructured":"Simon T, Verstuyft C, Mary-Krause M, et al.. Genetic determinants of response to clopidogrel and cardiovascular events. N Engl J Med. 2009, 360:363-375. 10.1056\/NEJMoa0808227","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/106646-a-peculiar-case-of-recurrent-coronary-artery-thrombosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:38:44Z","timestamp":1707507524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/106646-a-peculiar-case-of-recurrent-coronary-artery-thrombosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.29357","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,20]]}}}